Literature DB >> 27180789

Keloids and Hypertrophic Scars Can Now Be Cured Completely: Recent Progress in Our Understanding of the Pathogenesis of Keloids and Hypertrophic Scars and the Most Promising Current Therapeutic Strategy.

Rei Ogawa1, Satoshi Akaishi, Shigehiko Kuribayashi, Tsuguhiro Miyashita.   

Abstract

Keloids and hypertrophic scars are fibroproliferative disorders of the skin that are caused by abnormal healing of injured or irritated skin. It is possible that they are both manifestations of the same fibroproliferative skin disorder and just differ in terms of the intensity and duration of inflammation. These features may in turn be influenced by genetic, systemic, and local risk factors. Genetic factors may include single nucleotide polymorphisms, while systemic factors may include hypertension, pregnancy, hormones, and cytokines. The most important local factor is tension on the scar. Over the past 10 years, our understanding of the pathogenesis of keloids and hypertrophic scars has improved markedly. As a result, these previously intractable scars are now regarded as being treatable. There are many therapeutic options, including surgery, radiation, corticosteroids, 5-fluorouracil, cryotherapy, laser therapy, anti-allergy agents, anti-inflammatory agents, bleaching creams and make-up therapies. However, at present, we believe that the following combination of three therapies most reliably achieves a complete cure: surgery, followed by radiation and the use of steroid tape/plaster.

Entities:  

Mesh:

Year:  2016        PMID: 27180789     DOI: 10.1272/jnms.83.46

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  32 in total

1.  Keloid progression: a stiffness gap hypothesis.

Authors:  Chenyu Huang; Longwei Liu; Zhifeng You; Bingjie Wang; Yanan Du; Rei Ogawa
Journal:  Int Wound J       Date:  2016-12-19       Impact factor: 3.315

2.  Distensibility and Gross Elasticity of the Skin at Various Body Sites and Association with Pathological Scarring: A Case Study.

Authors:  Hitomi Sano; Yu Hokazono; Rei Ogawa
Journal:  J Clin Aesthet Dermatol       Date:  2018-06-01

Review 3.  Role of Inflammasomes in Keloids and Hypertrophic Scars-Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis.

Authors:  Chenyu Huang; Rei Ogawa
Journal:  Int J Mol Sci       Date:  2022-06-19       Impact factor: 6.208

4.  Dermatologic Microsutures Using Human Hair: A Useful Technique in Cutaneous Stitching.

Authors:  Mohammed Al Azrak; Rei Ogawa
Journal:  Eplasty       Date:  2017-08-21

Review 5.  Keloids: a review of therapeutic management.

Authors:  Samuel F Ekstein; Saranya P Wyles; Steven L Moran; Alexander Meves
Journal:  Int J Dermatol       Date:  2020-09-09       Impact factor: 3.204

6.  A Case of Keloids Complicated by Castleman's Disease: Interleukin-6 as a Keloid Risk Factor.

Authors:  Whitney L Quong; Yasuji Kozai; Rei Ogawa
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-05-16

Review 7.  Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?

Authors:  Jan Frohlich; Manlio Vinciguerra
Journal:  Geroscience       Date:  2020-10-06       Impact factor: 7.713

Review 8.  Mechanical and Immunological Regulation in Wound Healing and Skin Reconstruction.

Authors:  Shun Kimura; Takashi Tsuji
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 5.923

9.  Reconstruction after Anterior Chest Wall Keloid Resection Using Internal Mammary Artery Perforator Propeller Flaps.

Authors:  Rei Ogawa; Shimpei Ono; Satoshi Akaishi; Teruyuki Dohi; Takeshi Iimura; Junichi Nakao
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-09-29

Review 10.  Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.

Authors:  Rei Ogawa
Journal:  Int J Mol Sci       Date:  2017-03-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.